Jesús Aguilar, president of the General Pharmaceutical Council of Spain, appeared before the Health and Consumer Affairs Committee of the Congress of Deputies that is analysing the regulation of cannabis for medicinal use, on behalf of the pharmaceutical profession in Spain. His speech aimed to contribute to the ongoing debate on the use of cannabis for therapeutic purposes, providing the necessary elements of control and patient safety aspects regarding its use